Skip to main content
HERAMED LIMITED logo

HERAMED LIMITED — Investor Relations & Filings

Ticker · HMD ISIN · AU0000028367 LEI · 875500WOB41XBFTTJ477 ASX Manufacturing
Open in API
Filings indexed 524 across all filing types
Latest filing 2024-01-17 Capital/Financing Update
Country AU Australia
Listing ASX HMD

About HERAMED LIMITED

https://hera-med.com/

HeraMED Limited is a medical technology company specializing in the development and commercialization of digital health solutions for maternity care. The company focuses on providing remote monitoring tools that bridge the gap between expectant mothers and healthcare providers. Its flagship product, HeraBEAT, is a medical-grade, smartphone-based fetal heart rate monitor designed for home use, allowing for accurate and reliable monitoring of fetal well-being. This hardware is integrated into the HeraCARE platform, a comprehensive digital maternity care solution that enables remote data management, personalized care plans, and seamless communication between patients and clinicians. By leveraging cloud-based technology and advanced sensors, the company aims to enhance prenatal care, improve clinical outcomes, and offer peace of mind through continuous, data-driven insights throughout the pregnancy journey.

Recent filings

Filing Released Lang Actions
Non-Renounceable Issue 20 pages 1.6MB
Capital/Financing Update Classification · 100% confidence The document is titled 'Rights Issue Offer Booklet' and details a non-renounceable pro rata rights issue offer by HeraMED Limited. It includes specifics about the offer price, ratio, timetable, use of funds, capital structure, and risks associated with the offer. The content is focused on informing shareholders about the rights issue and how to participate, including legal disclaimers and regulatory compliance notes. This is a detailed offer document related to capital raising through a rights issue, which fits the category of Capital/Financing Update (CAP). It is not an announcement of a report, nor is it a full financial report or earnings release. The length and detail confirm it is the offer document itself, not just a brief announcement or notice.
2024-01-17 English
Non-Executive Director Resignation 1 page 100.1KB
Board/Management Information Classification · 100% confidence The document is an ASX announcement dated 17 January 2024 regarding the resignation of a Non-Executive Director, Emily Slade, effective immediately. It includes statements of thanks and quotes from the Chair but contains no financial data, no report or presentation, and no mention of voting results or other regulatory filings. The content clearly relates to a change in the company's board of directors. Therefore, the document fits the category of Board/Management Information (MANG). The document length is short and focused solely on this announcement, confirming it is not a full report or other filing type.
2024-01-16 English
Final Director's Interest Notice Emily Slade 2 pages 263.6KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Z Final Director’s Interest Notice' and references ASX listing rule 3.19A.3 and section 205G of the Corporations Act. It details the cessation of a director and the director's interests in securities, with no securities held or contracts disclosed. This is a report of personal share transactions or holdings by a company director, which fits the definition of Director's Dealing filings. The document length is short and focused solely on director interests, not financial results or other report types.
2024-01-16 English
Strategic collaboration and commercial agreement with GPEx 4 pages 157.9KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 16 January 2024, describing a strategic collaboration and commercial agreement between HeraMED Limited and GPEx. It details the terms of a pilot program, objectives, and expected outcomes of the collaboration, focusing on healthcare technology deployment and commercial partnership. There are no financial statements, quarterly or annual results, or regulatory filings such as audit reports or management discussions. The content is primarily an announcement of a business collaboration and commercial agreement, not a financial report or regulatory filing. Therefore, the document fits best under Capital/Financing Update (CAP) as it relates to a commercial agreement and pilot program with revenue and activity share model post-pilot success, indicating financing and capital structure implications.
2024-01-15 English
Application for quotation of securities - HMD 6 pages 28.0KB
Capital/Financing Update Classification · 100% confidence The document is an application for quotation of securities on the ASX by Heramed Limited. It details the number and type of securities to be quoted, issue dates, distribution schedules, and issued capital following quotation. It references previous announcements and Appendix 3B filings related to the securities issuance. The content focuses on the listing and quotation of new securities rather than financial results, management changes, or other report types. This fits the category of a Capital/Financing Update, as it concerns the issuance and quotation of new shares and related securities.
2023-12-21 English
Cleansing Notice 1 page 81.9KB
Capital/Financing Update Classification · 95% confidence The document is a short announcement dated 22 December 2023, titled 'Section 708A(5) Cleansing Notice' related to the issue of 41,750,000 fully paid ordinary shares by HeraMED Limited. It references compliance with the Corporations Act and ASX Listing Rules, specifically Listing Rule 7.1, and mentions an appendix 2A lodged on the ASX. The content is about notifying the market of a share issue and compliance with disclosure requirements, not a full financial report or detailed analysis. The document length is only 1293 characters, indicating it is a brief announcement rather than a detailed report. This fits the category of a Capital/Financing Update (CAP) as it relates to company fundraising and capital structure changes through share issuance.
2023-12-21 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.